info@ehidc.org

 202-624-3270

Insights from Pharmaceutical Manufacturers & Payers: Addressing Social Determinants of Health and Advancing Health Equity

Social Determinants of Health

Insights from Pharmaceutical Manufacturers & Payers: Addressing Social Determinants of Health and Advancing Health Equity

August 10, 2020

This report outlines several key findings, which were developed after convening pharmaceutical manufacturers, health plans, community based SDOH programs, patient advocacy organizations, and other experts. Merck and Boehringer Ingelheim Pharmaceuticals, Inc. participated and provided financial support for development of the report. Findings addressed in the report include:

  • Using COVID-19 as a catalyst for change
  • The role of data in advancing health equity
  • A shared SDOH framework
  • Tools for putting SDOH into action
  • Using data to understand health while addressing social risk
  • Appropriate use of SDOH
  • SDOH and health literacy
  • Positive benefits of SDOH

“The pandemic has revealed dramatic disparities in testing, care, treatment and health outcomes across minority populations” said Jen Covich Bordenick, Chief Executive Officer of eHI. “It was encouraging to learn about the different partnerships that pharmaceutical manufacturers and payers are leveraging to tackle the issues.”

 

Share